{
  "id": 11442973,
  "title": "Cuprina to acquire Singapore clinics for S$4.0 million",
  "url": "https://urgent.news/2026/10/02/cuprina-to-acquire-singapore-clinics-for-s-4-0-million",
  "topic": "business",
  "section": "Business",
  "published": "2026-10-02T13:04:33.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/cuprina-to-acquire-singapore-clinics-for-s40-million-93CH-4929894"
  },
  "original_language": "en",
  "account": "Singapore-based biomedical firm Cuprina Holdings has entered into agreements to acquire two clinics in Singapore for approximately S$4.0 million. The deal, finalized by Cuprina Holdings (BVI) Limited, will be paid 75% in cash and 25% in the company's shares. The cash portion of S$3.0 million is payable upfront, with the remainder spread across two installments. Shares, subject to a lock-up period, will also be exchanged. Cuprina Holdings will assume the combined revenue of S$9.1 million and normalized EBITDA of S$1.2 million for the year ending December 31, 2025. The transaction, expected to close by November 1, 2026, hinges on customary closing conditions. Post-acquisition, financial results will be consolidated under Cuprina's umbrella. Cuprina specializes in developing products for chronic wounds, infertility, medical waste recycling, and cosmeceuticals.",
  "summary": null,
  "key_points": [
    "Cuprina acquires two Singapore clinics for S$4.0 million",
    "75% cash payment upfront, remainder in two installments",
    "Transaction closes by November 1, 2026, subject to conditions"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}